Gamaleya Center
-
Sputnik V induces robust neutralising antibody response to Omicron variant: Study
Sputnik Light has already been registered in more than 20 countries as a standalone vaccine A preliminary laboratory study conducted…
Read More » -
RDIF collaborates with India for one-shot Sputnik Light, Sputnik M vaccines
Results of a separate joint clinical trial of a combination of Sputnik Light with the AstraZeneca vaccine have demonstrated that…
Read More » -
Sputnik V vaccine’s efficacy confirmed at 91.4 per cent
This is based on data analysis of the final control point of clinical trials The National Research Center for Epidemiology…
Read More » -
Sputnik V vaccine to cost less than $10 for international markets
RDIF continues expanding existing agreements with international manufacturing partners to produce the vaccine for more than 500 million people in…
Read More »